Co-dispensing of contraindicated medications in patients using cisapride in Italy

Pharmacoepidemiology and Drug Safety

Volumn 15, Issue 7, 2006, Pages 469-476

  Staniscia, Tommaso ^a   Romano, Ferdinando ^b   Festi, Davide ^c   Bilker, Warren B ^d   Macones, George A ^d   Strom, Brian L ^d  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cisapride; Co dispensing; Contraindicated drugs; Drug utilization

Indexed keywords

AMIODARONE; AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZITHROMYCIN; CISAPRIDE; CLARITHROMYCIN; DISOPYRAMIDE; ERYTHROMYCIN; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MACROLIDE; MAPROTILINE; MICONAZOLE; NEFAZODONE; NEUROLEPTIC AGENT; PHENOTHIAZINE DERIVATIVE; PIMOZIDE; PROCAINAMIDE; PROTEINASE INHIBITOR; PYRROLE DERIVATIVE; QUINIDINE; SERTINDOLE; SOTALOL; TERFENADINE; TROLEANDOMYCIN; UNINDEXED DRUG;

ADOLESCENT; ADULT; ARTICLE; CALCULATION; CHILD; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG USE; FEMALE; HEART ARRHYTHMIA; HUMAN; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QT PROLONGATION; RISK FACTOR; SEX RATIO;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CISAPRIDE; DRUG INTERACTIONS; DRUG UTILIZATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 33746620821     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1246     Document Type: Article

References (17)

1. Wiseman LR, Faulds D. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994; 47: 116-152.
2. Walker AM, Szneke P, Weatherby LB, et al. The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada. Am J Med 1999; 107: 356-362.
3. Enger C, Cali C, Walker AM. Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States. Pharmacoepidemiol Drug Saf 2002; 11: 477-486.
4. Barbey JT, Lazzara R, Zipes DP. Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisapride. J Cardiovasc Pharmacol Ther 2002; 7: 65-76.
5. Michalets EL, Williams CR. Drug interactions with cisapride: clinical implications. Clin Pharmacokinet 2000; 39: 49-75.
6. Bran S, Murray WA, Hirsch IB, Palmer JP. Long QT syndrome during high-dose cisapride. Arch Intern Med 1995; 155: 765-768.
7. Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med 1996; 335: 290-291.
8. Sturkenboom MC, Romano F, Simon G, et al. The iatrogenic costs of NSAID therapy: a population study. Arthritis Rheum 2002; 15: 132-140.
9. DURG-Italia - Archivio delle DDD dei farmaci in commercio in Italia. 1999.
10. Raschetti R, Maggini M, Da Cas R, Popoli P, Rossi A. Time trends in the coprescribing of cisapride and contraindicated drugs in Umbria, Italy. JAMA 2001; 285: 1840-1841.
11. Smalley W, Shatin D, Wysowski DK, et al. Contraindicated use of cisapride: impact of food and drug administration regulatory action. JAMA 2000; 284: 3036-3039.
12. Food and drug Administration. Withdrawal of troglitazone and cisapride. JAMA 2000; 283: 2228.
13. Weatherby LB, Walker AM, Fife D, Vervaet P, Klausner MA. Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of 'Dear Doctor' letters. Pharmacoepidemiol Drug Safe 2001; 10: 211-218.
14. Jones JK, Fife D, Curkendall S, Goehring E, Jr, Guo JJ, Shannon M. Coprescribing and codispensing of cisapride and contraindicated drugs. Jama 2001; 286: 1607-1609.
15. Guo JJ, Curkendall S, Jones JK, Fife D, Goehring E, She D. Impact of cisapride label changes on codispensing of contraindicated medications. Pharmacoepidemiol Drug Safe 2003; 12: 295-301.
16. Guedon-Moreau L, Ducrocq D, Duc MF, et al. Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999. Eur J Clin Pharmacol 2003; 59: 689-695.
17. McMullin ST, Reichley RM, Watson LA, Steib SA, Frisse ME, Bailey TC. Impact of a Web-based clinical information system on cisapride drug interactions and patient safety. Arch Intern Med 1999; 159: 2077-2082.